Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C

NCT02971033 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

FED

Sponsor class

Stopped Study Funding ended

Conditions

Chronic Hepatitis C

Interventions

DRUG: 20mg ezetimibe
DRUG: Placebo
DRUG: 40mg ezetimibe

Sponsor

VA Office of Research and Development